FindTrial
Sign In

Pregestational diabetes mellitus among antenatal mothers

Prevalence, determinants, and outcomes in Pre gestational Diabetes (PGDM): A hospital-based cohort study in Ernakulam district - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/06/068978
Enrollment
2450
Registered
2024-06-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: NA Control Intervention1: Nil: NA

Sponsors

Amrita Institute of Medical Sciences and Research Center Amrita Hospital KochiKerala India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women with confirmed pregnancy on Early Pregnancy Scan Women in the first trimester of pregnancy, calculated from the last menstrual period.

Exclusion criteria

Exclusion criteria: Women with psychiatric illness. Women under steroid therapy.

Design outcomes

Primary

MeasureTime frame
To estimate the Prevalence of Pre-gestational Diabetes Mellitus (PGDM) during the first trimester of pregnancy among antenatal mothers.Timepoint: At baseline—

Secondary

MeasureTime frame
To dentify the maternal outcomes during pregnancy, delivery, & post-natal period among mothers.Timepoint: 20 -24 weeks of pregnancy and 32-36 weeks of pregnancy;To enumerate the determinants of Pre-gestational Diabetes Mellitus (PGDM) among antenatal mothers.Timepoint: At baseline;To find the neonatal outcomes during the neonatal period among newborns.Timepoint: At birth of the baby—

Countries

India

Contacts

Public ContactAnju Philip Thurkkada

AMRITA VISHWAVIDYAPEETHAM

radhamanyk@aims.amrita.edu9847044741

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026